One-Month versus Three-Month Formulation of Paliperidone Palmitate Treatment in Psychotic Disorders: Patients’, Relatives’, and Mental Health Professionals’ Perspectives

PURPOSE: Paliperidone palmitate is the only available long acting injectable (LAI) antipsychotic with a monthly and three-monthly formulation. LAIs may help battle non-adherence. Studies about the experiences of switching from the monthly (PP1M) to the three-monthly formulation (PP3M) of paliperidon...

Descripción completa

Detalles Bibliográficos
Autores principales: Spoelstra, S Kor, Bruins, Jojanneke, Bais, Leonie, Seerden, Paul, Castelein, Stynke, Knegtering, Henderikus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904433/
https://www.ncbi.nlm.nih.gov/pubmed/35283623
http://dx.doi.org/10.2147/PPA.S349460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904433/
https://www.ncbi.nlm.nih.gov/pubmed/35283623
http://dx.doi.org/10.2147/PPA.S349460

Ejemplares similares